Sheila Gujrathi is the CEO of Gossamer Bio, a San Diego biotech seeking $264.5 million through an initial public offering. Photo courtesy of Gossamer Bio

Sheila Gujrathi is the CEO of Gossamer Bio, a San Diego biotech seeking $264.5 million through an initial public offering. Photo courtesy of Gossamer Bio Photo by Jamie Scott Lytle.

As evidenced by a planned Nasdaq listing, Gossamer Bio has grand plans...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129